558 related articles for article (PubMed ID: 33268944)
1. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.
Chrysavgis L; Ztriva E; Protopapas A; Tziomalos K; Cholongitas E
World J Gastroenterol; 2020 Nov; 26(42):6514-6528. PubMed ID: 33268944
[TBL] [Abstract][Full Text] [Related]
2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
3. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
4. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
Long MT; Noureddin M; Lim JK
Gastroenterology; 2022 Sep; 163(3):764-774.e1. PubMed ID: 35842345
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
[TBL] [Abstract][Full Text] [Related]
7. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
[TBL] [Abstract][Full Text] [Related]
8. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
Lin CL; Tai CM; Huang JF; Liu CJ; Chen HF; Cheng PN; Chen CY; Peng CY; Wang CC; Weng SH; Tseng TC; Kao JH
J Gastroenterol Hepatol; 2022 Oct; 37(10):1901-1910. PubMed ID: 35790343
[TBL] [Abstract][Full Text] [Related]
9. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
[TBL] [Abstract][Full Text] [Related]
10. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
11. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
12. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
[TBL] [Abstract][Full Text] [Related]
13. Special Population: Lean Nonalcoholic Fatty Liver Disease.
Duseja A; De A; Wong V
Clin Liver Dis; 2023 May; 27(2):451-469. PubMed ID: 37024218
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment.
Patel AH; Peddu D; Amin S; Elsaid MI; Minacapelli CD; Chandler TM; Catalano C; Rustgi VK
J Clin Transl Hepatol; 2023 Apr; 11(2):502-515. PubMed ID: 36643037
[TBL] [Abstract][Full Text] [Related]
15. Impact of body mass index on disease progression and outcomes in patients with nonalcoholic fatty liver disease.
Biswas S; Vaishnav M; Farooqui N; Aggarwal A; Pathak P; Yadav R; Das P; Elhence A; Goel A; Mishra AK; Shalimar
Postgrad Med J; 2023 Sep; 99(1176):1094-1103. PubMed ID: 37308443
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease.
Kim Y; Han E; Lee JS; Lee HW; Kim BK; Kim MK; Kim HS; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Lee YH; Kim SU
Gut Liver; 2022 Mar; 16(2):290-299. PubMed ID: 34238770
[TBL] [Abstract][Full Text] [Related]
17. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study.
Ahmed OT; Gidener T; Mara KC; Larson JJ; Therneau TM; Allen AM
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1374-1381.e6. PubMed ID: 34265444
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
[TBL] [Abstract][Full Text] [Related]
19. New trends on obesity and NAFLD in Asia.
Fan JG; Kim SU; Wong VW
J Hepatol; 2017 Oct; 67(4):862-873. PubMed ID: 28642059
[TBL] [Abstract][Full Text] [Related]
20. Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects.
Feldman A; Wernly B; Strebinger G; Eder SK; Zandanell S; Niederseer D; Strasser M; Haufe H; Sotlar K; Paulweber B; Datz C; Aigner E
J Gastrointestin Liver Dis; 2021 Sep; 30(3):366-373. PubMed ID: 34375373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
